Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorSecond Affiliated Hospital of Xi'an Jiaotong University

About this trial

How to accurately and safely evaluate regional liver function before hepatectomy remains an important unsolved problem in the surgical management of hepatocellular carcinoma (HCC). We plan to develop a non-invasive, functional 3D-MRE-based method for preoperative regional hepatic functional reserve assessment, and to evaluate its ability to predict surgical risk and postoperative liver failure in patients with HCC undergoing hepatectomy.

Eligibility criteria

Qualifiers

Age 18-80 years

Pathologically or radiologically confirmed diagnosis of one of the following: hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or liver metastasis (e.g., from colorectal cancer)

Scheduled to undergo curative hepatectomy

Child-Pugh class A or B liver function

Disqualifiers

Contraindication to MRI (e.g., non-MRI-compatible implants, severe claustrophobia)

Child-Pugh class C liver function

Prior history of liver resection or liver transplantation

Presence of extrahepatic metastasis

Trial design

Treatments tested in this trial

  • Three-Dimensional Magnetic Resonance Elastography

Treatment groups

No treatment groups listed

Locations

This trial has no locations